Actinium Pharmaceuticals Inc ATNM:NYSE American

Last Price$5.91AMEX Previous Close - Last Trade as of 8:00PM ET 8/12/22
AMEX 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$5.65 (3)
Ask (Size)$5.90 (3)
Day Low / HighN/A - N/A
Volume124.6 K
 

View Pharmaceuticals: Major IndustryPeer Comparison as of 08/12/2022

 

Actinium Pharmaceuticals Inc ( NYSE MKT LLC )

Price: $5.91
Change: +0.21 (3.68%)
Volume: 124.6 K
8:00PM ET 8/12/2022
 
 

NextCure Inc ( NASDAQ )

Price: $5.09
Change: +0.04 (0.79%)
Volume: 202.2 K
4:00PM ET 8/12/2022
 
 

Sesen Bio Inc ( NASDAQ )

Price: $0.70
Change: -0.004 (0.55%)
Volume: 1.2 M
4:00PM ET 8/12/2022
 
 

TCR2 Therapeutics Inc ( NASDAQ )

Price: $3.70
Change: +0.07 (1.93%)
Volume: 226.0 K
4:00PM ET 8/12/2022
 
 

Ardelyx Inc ( NASDAQ )

Price: $0.93
Change: +0.03 (3.89%)
Volume: 2.0 M
4:00PM ET 8/12/2022
 

Read more news Recent News

--Alliance Global Adjusts Price Target on Actinium Pharmaceuticals to $25 From $20, Maintains Buy Rating
5:37AM ET 4/13/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Sector Update: Health Care Stocks Ending Near Intra-Day Lows
3:56PM ET 4/12/2022 MT Newswires

Health care stocks extended their Tuesday slide, with the NYSE Health Care Index sinking 1.3% and the SPDR Health Care Select Sector ETF (XLV) down 1.2%...

Sector Update: Health Care Stocks Drifting Lower Tuesday Afternoon
1:45PM ET 4/12/2022 MT Newswires

Health care stocks were mostly lower this afternoon, with the NYSE Health Care Index sinking 0.6% and the SPDR Health Care Select Sector ETF (XLV) down...

Top Midday Gainers
1:42PM ET 4/12/2022 MT Newswires

LIXTE Biotechnology (LIXT) on Tuesday disclosed pre-clinical results of its collaboration with the Netherlands Cancer Institute, revealing the anti-cancer...

View all Commentary and Analysis

Actinium Pharmaceuticals (ATNM) Investor Presentation - Slideshow
2:14PM ET 4/13/2022 Seeking Alpha

Actinium: Promises, Promises
5:09PM ET 3/11/2022 Seeking Alpha

Actinium Pharmaceuticals, Inc. (ATNM) Investor Presentation - Slideshow
11:56AM ET 2/07/2022 Seeking Alpha

Actinium: SIERRA Is Progressing Well Towards Final Data Readout
9:05AM ET 12/16/2021 Seeking Alpha

Company Profile

Business DescriptionActinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel targeted therapies known as Antibody Radiation-Conjugates, which combine the targeting ability of antibodies with the cell killing ability of radiation. The company was founded in 2000 and is headquartered in New York, NY. View company web site for more details
Address275 Madison Avenue
New York, New York 10016
Phone+1.646.677.3870
Number of Employees30
Recent SEC Filing08/12/202210-Q
Chairman & Chief Executive OfficerSandesh Seth
Chief Financial OfficerSteve O'Loughlin
Chief Medical OfficerAvinash Desai
Vice President-Clinical DevelopmentMary Mei Chen

Company Highlights

Price Open$5.82
Previous Close$5.70
52 Week Range$4.41 - 10.30
Market Capitalization$140.6 M
Shares Outstanding23.8 M
SectorHealth Technology
IndustryPharmaceuticals: Major
Next Earnings Announcement08/12/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.14
Beta vs. S&P 500N/A
Revenue$0.00
Net Profit Margin-1,681.46%
Return on Equity-32.44%

Analyst Ratings as of 07/21/2022

Buy
3
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset